Latest Breaking News On - Eiger biopharmaceuticals - Page 2 : comparemela.com

StockNews com Begins Coverage on Eiger BioPharmaceuticals (NASDAQ:EIGR)

Investment analysts at StockNews.com started coverage on shares of Eiger BioPharmaceuticals (NASDAQ:EIGR – Get Free Report) in a research note issued on Thursday. The firm set a “sell” rating on the biotechnology company’s stock. Eiger BioPharmaceuticals Price Performance Eiger BioPharmaceuticals has a 52-week low of $1.10 and a 52-week high of $43.35. The stock has […]

United statesEiger biopharmaceuticals incEiger biopharmaceuticalsGet free reportEiger biopharmaceuticals dailyNasdaq eigrInitiated coverageStocknews com

StockNews com Initiates Coverage on Eiger BioPharmaceuticals (NASDAQ:EIGR)

StockNews com Initiates Coverage on Eiger BioPharmaceuticals (NASDAQ:EIGR)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesEiger biopharmaceuticals incEiger biopharmaceuticalsFree reportGet free reportEiger biopharmaceuticals daily

StockNews com Begins Coverage on Eiger BioPharmaceuticals (NASDAQ:EIGR)

StockNews.com started coverage on shares of Eiger BioPharmaceuticals (NASDAQ:EIGR – Free Report) in a research note published on Tuesday. The firm issued a sell rating on the biotechnology company’s stock. Eiger BioPharmaceuticals Stock Performance The stock’s 50-day moving average is $5.04 and its 200 day moving average is $7.14. The firm has a market cap […]

United statesEiger biopharmaceuticals company profileBarclays plcEiger biopharmaceuticals incCapital managementMillennium managementAmeriprise financial incEiger biopharmaceuticalsFree reportGet free reportEiger biopharmaceuticals daily

Eiger BioPharmaceuticals (NASDAQ:EIGR) Earns Sell Rating from Analysts at StockNews com

StockNews.com began coverage on shares of Eiger BioPharmaceuticals (NASDAQ:EIGR – Free Report) in a research report released on Tuesday. The brokerage issued a sell rating on the biotechnology company’s stock. Eiger BioPharmaceuticals Price Performance The firm has a 50 day moving average of $5.04 and a 200-day moving average of $7.14. Eiger BioPharmaceuticals has a […]

United statesMorgan stanleyEiger biopharmaceuticals incAmeriprise financial incVanguard group incBarclays plcEiger biopharmaceuticals company profileEiger biopharmaceuticalsFree reportStreet corpGet free reportEiger biopharmaceuticals daily

Eton Pharmaceuticals Inc (ETON) Enters Share and Warrant Sale Agreements

Eton Pharmaceuticals Inc (ETON) Enters Share and Warrant Sale Agreements
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Eton pharmaceuticals incEiger biopharmaceuticals incEton pharmaceuticalsEiger biopharmaceuticalsWednesday april